Safety and efficacy of Panax ginseng during pregnancy and lactation

Canadian Journal of Clinical Pharmacology

Volumn 15, Issue 1, 2008, Pages

  Seely, Dugald ^a,b   Dugoua, Jean Jacques ^a,b,c   Perri, Daniel ^b   Mills, Edward ^a,d   Koren, Gideon ^b,c  

^a CANADIAN COLLEGE OF NATUROPATHIC MEDICINE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Asian ginseng; Breastfeeding; Ginseng; Lactation; Panax ginseng; Pregnancy; Systematic review

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; CAFFEINE; CENTRAL STIMULANT AGENT; ESTRADIOL; FOLLITROPIN; FUROSEMIDE; GINSENG EXTRACT; IMMUNOSUPPRESSIVE AGENT; INSULIN; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PLACEBO; WARFARIN;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CHRONIC BRONCHITIS; CLINICAL TRIAL; COGNITION; COMMON COLD; CONFUSION; DEPERSONALIZATION; DEPRESSION; DIARRHEA; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENDOMETRIUM; ENZYME ACTIVITY; ERECTILE DYSFUNCTION; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; FOLLITROPIN BLOOD LEVEL; GINSENG; GINSENG ABUSE SYNDROME; HERBAL MEDICINE; HUMAN; HYPERTENSION; IN VITRO STUDY; INFLUENZA; INSOMNIA; LACTATION; MASTALGIA; MEMORY; MENOPAUSAL SYNDROME; NERVOUSNESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PARKINSON DISEASE; PREGNANCY; PREGNANT WOMAN; PREMATURE EJACULATION; RASH; SIDE EFFECT; SYSTEMATIC REVIEW; TERATOGENICITY; TREATMENT INDICATION; VAGINA BLEEDING;

EID: 38549156045     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Radad K, et al. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci 2006;100(3):175-86.
2. Bahrke MS, Morgan WR. Evaluation of the ergogenic properties of ginseng: an update. Sports Med 2000;29(2):113-33.
3. Boon H, Smith M. The complete natural medicine guide to the 50 most common medicinal herbs. 2004, Toronto: Robert Rose.
4. Blumenthal M. Asian ginseng: potential therapeutic uses. Adv Nurse Pract 2001;9(2):26-8, 33.
5. Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf 2002;25(5):323-44.
6. Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol 1999;55(8):567-75.
7. Jellin JM, Batz F, Hitchens K. Natural medicines comprehensive database 3rd Edition. 2002, Stockton, CA: Therapeutic Research Faculty. 1530.
8. Moon J, et al. Induction of G(1) cell cycle arrest and p27(KIP1) increase by panaxydol isolated from Panax ginseng. Biochem Pharmacol 2000;59:1109-16.
9. Ng TB, Wang H. Panaxagin, a new protein from Chinese ginseng possesses anti-fungal, anti-viral, translation-inhibiting and ribonuclease activities. Life Sci 2001;68:739-49.
10. Foster S. Panax ginseng. American Botanical Council, 1996.
11. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. 1996, New York, NY: John Wiley & Sons. 649.
12. Hong B, et al. A double-blind crossover study evaluating the efficacy of korean red ginseng in patients with erectile dysfunction: a preliminary report. J Urol 2002;168(5):2070-3.
13. Choi HK, et al. Clinical study of SS-Cream in patients with lifelong premature ejaculation. Urology 2000;55:257-61.
14. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin dependent diabetic patients. Diabetes Care 1995;18:1373-5.
15. Scaglione F, et al. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected]. Drugs Exp Clin Res 1996;22(2):65-72.
16. Wesnes KA, et al. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl) 2000;152(4)353-61.
17. Scholey AB, Kennedy DO. Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum Psychopharmacol 2002;17(1):35-44.
18. The Review of Natural Products by Facts and Comparisons. 1999, St. Louis, MO: Wolters Kluwer Co.
19. Sorensen H, Sonne J. A double-masked study of the effects of ginseng on cognitive functions. Curr Ther Res Clin Exp 1996;57:959-68.
20. D'Angelo L, et al. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. J Ethnopharmacol 1986;16(1):15-22.
21. Reay JL, Kennedy D, Scholey A. Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained 'mentally demanding' tasks. J Psychopharmacol 2006;20(6):771-781.
22. Reay JL, Kennedy DO, Scholey AB. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. J Psychopharmacol 2005;19(4):357-65.
23. Kim SH, et al. Effects of Panax ginseng extract on exercise-induced oxidative stress. J Sports Med Phys Fitness 2005;45(2):178-82.
24. Scaglione F, Weiser K, Alessandria M. Effects of the standardized ginseng extract G115 (Reg.) in patients with chronic bronchitis: A nonblinded, randomized, comparative pilot study. Clin Drug Invest 2001;21:41-5.
25. Yun TK, Choi SY. Non-organ specific cancer prevention of ginseng: a prospective study in Korea. Int J Epidemiol 1998;27(3):359-64.
26. Shin HR, et al. The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control 2000;11:565-76.
27. Van Kampen JM, Robertson HA. A possible role for dopamine D3 receptor stimulation in the induction of neurogenesis in the adult rat substantia nigra. Neuroscience 2005;136(2):381-6.
28. Wiklund IK, et al. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Int J Clin Pharmacol Res 1999;19:89-99.
29. Zhang WY, Teng H, Zheng Y. [Ginseng saponin treatment for intrauterine growth retardation]. Zhonghua Yi Xue Za Zhi 1994;74(10):608-10, 646.
30. Farnsworth NR, et al. Potential value of plants as sources of new antifertility agents II. J. Pharm Sci. 1975;64(5):717-753.
31. Awang DV. Maternal use of ginseng and neonatal androgenization. JAMA 1991;266(3):363.
32. Koren G, et al. Maternal ginseng use associated with neonatal androgenization. JAMA 1990;264:2866.
33. Okamura N, et al. Protective effect of ginseng saponins against impaired brain growth in neonatal rats exposed to ethanol. Biol Pharm Bull 1994;17(2):270-4.
34. Chan LY, Chiu PY, Lau TK. An in-vitro study of ginsenoside Rb1-induced teratogenicity using a whole rat embryo culture model. Hum Reprod 2003;18(10):2166-8.
35. Liu P, et al. Developmental toxicity research of ginsenoside Rb1 using a whole mouse embryo culture model. Birth Defects Res B Dev Reprod Toxicol 2005;74(2):207-9.
36. Liu P, et al. Effects of ginsenoside Rg1 on postimplantation rat and mouse embryos cultured in vitro. Toxicol In Vitro 2006;20(2):234-8.
37. Chan LY, Chiu PY, Lau TK. Embryotoxicity study of ginsenoside Rc and Re in in vitro rat whole embryo culture. Reprod Toxicol 2004;19(1):131-4.
38. Cho SW, Cho EH, Choi SY. Ginsenosides activate DNA polymerase delta from bovine placenta. Life Sci 1995;57(14):1359-65.
39. Wong HB. Effects of herbs and drugs during pregnancy and lactation. J Singapore Paediatr Soc 1979;21(3-4):169-78.
40. Palmer BV, et al. Gin Seng and mastalgia [letter]. BMJ 1978;1:1284.
41. Hopkins MP, Androff L, Benninghoff AS. Ginseng face cream and unexplained vaginal bleeding. Am J Obstet Gynecol 1988;159:1121-2.
42. Greenspan EM. Ginseng and vaginal bleeding [letter]. JAMA 1983;249:2018.
43. Hammond TG, Whitworth JA. Adverse reactions to ginseng [letter]. Med J Aust 1981;1:492.
44. Punnonen R, Lukola A. Oestrogen-like effect of ginseng. Br Med J 1980;281:1110.
45. Eagon PK, et al. Medicinal herbs: modulation of estrogen action. in Era of Hope Mtg, Dept Defense. 2000. Atlanta, GA: Breast Cancer Res Prog.
46. Lee YJ, et al. Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Arch Pharm Res 2003;26:58-63.
47. Hu S, et al. Effect of subcutaneous injection of ginseng on cows with subclinical Staphylococcus aureus mastitis. J Vet Med B Infect Dis Vet Public Health 2001;48(7):519-28.
48. Concha C, Hu S, Holmberg O. The proliferative responses of cow stripping milk and blood lymphocytes to pokeweed mitogen and ginseng in vitro. Vet Res 1996;27(2):107-15.
49. Hu S, et al. Ginseng-enhanced oxidative and phagocytic activities of polymorphonuclear leucocytes from bovine peripheral blood and stripping milk. Vet Res 1995;26(3):155-61.
50. Chang YS, et al. Panax ginseng: a role in cancer therapy? Integr Cancer Ther 2003;2(1):13-33.
51. Siegel RK. Ginseng abuse syndrome. Problems with the panacea. JAMA 1979;241(15):1614-5.
52. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58(11):1685-93.
53. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997;54:692-3.
54. Cheng TO. Ginseng-warfarin interaction. ACC Current Journal Review 2000;9(1):84.
55. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin dependent diabetic patients. Diabetes Care 1993;Jan;16(1):8-15, 1995;18:1373-5.
56. Newall CA, Anderson LA, Phillipson JD. Herbal medicines: a guide for health-care professionals. 1996, London, UK: Pharmaceutical Press 296.
57. Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. 1998, Sandy, OR: Eclectic Medical Publications.
58. Becker BN. Ginseng-induced diuretic resistance. JAMA 1996;276(8):606-7.
59. Shader RI, Greenblatt DJ. Phenylzine and the dream machine-ramblings and reflections. J Clin Psychopharmacol 1985;5:65.
60. Jones BD, Runikis AM. Interaction of ginseng with phenelzine. J Clin Psychopharmacol 1987;7:201-2.
61. McGuffin M, et al. American Herbal Products Association's Botanical Safety Handbook. 1997, Boca Raton, FL: CRC Press. 231.
62. Zhu M, et al. Possible influences of ginseng on the pharmacodynamics of warfarin in rats. J Pharm Pharmacol 1999;51:175-80.
63. Steiner M. Untersuchungen zur odemvermindernden und odemportektiven wirking von ro kastaniensamenextrakt. Phlebol Prokto 1990;19:239-42.
64. Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebo-controlled trial. Obstet Gynecol 2001;97(4):577-82.
65. Tode T, et al. Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. Int J Gynaecol Obstet 1999;67:169-74.
66. Hiai S, et al. Stimulation of pituitary-adrenocortical system by ginseng saponin. Endocrinol Jpn 1979;26:661-5.
67. Kase Y, et al. Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levels. Biol Pharm Bull 1998;21:1277-81.
68. Robbers JE, Speedie MK, Tyler VE. Pharmacognosy and Pharmacobiotechnology. 1996, Baltimore, MD: Williams & Wilkins.
69. Belogortseva NI, Yoon JY, Kim KH. Inhibition of Helicobacter pylori hemagglutination by polysaccharide fractions from roots of Panax ginseng. Planta Med 2000;66:217-20.
70. Schulz V, et al. Rational Phytotherapy: A Physician's Guide to Herbal Medicine. 3rd ed. 1998, Berlin, GER: Springer.
71. Lewis R, et al. Non-ginsenoside nicotinic activity in ginseng species. Phytother Res 1999;13:59-64.
72. Tamaoki J, Nakata J, Kawatani K. Ginsenoside-induced relaxation of human bronchial smooth muscle via release of nitric oxide. Br J Pharmacol 2000;130:1859-64.
73. Pan SJ, Ding Z, Ivy JL. Ginseng's effects on glucose tolerance and mRNA profiles in an animal model of Type II diabetes. Alt Ther 2001;7:S26.